Recerca

Sarcomes i Histiocitosis

Buscador de publicacions

Publicacions

  • Carrere X, Pinto N, Gene-Olaciregui N, Galluzzo L, Rossetti E, Celis-Passini V, Salvador-Marcos N, Chantada G, Braier J, Lavarino C and Felizzia G.

    High prevalence of BRAF(V600E) in patients with cholestasis, sclerosing cholangitis or liver fibrosis secondary to Langerhans cell histiocytosis

    PEDIATRIC BLOOD & CANCER . 68(7): 29115. Nº de cites: 2

    [doi:10.1002/pbc.29115]

  • Castillo H, Pascual-Pastó G, Pérez-Jaume S, Resa-Parés C, Vilà-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farrés M, Muñoz-Aznar O, Salvador-Marcos N, Cuadrado-Vilanova M, Gene-Olaciregui N, Balaguer-Lluna L, Burgeño-Sandoval V, Vicario FJ, Manzanares-Quintela A, Castañeda-Heredia A, Santa-María López V, Cruz-Martínez O, Celis-Passini V, Morales-La Madrid A, Garraus-Oneca M, Gorostegui M, Vancells M, Carrasco-Torrents R, Krauel L, Torner-Rubies F, Suñol M, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas

    JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 7(4): 338-349. Nº de cites: 14

    [doi:10.1002/cjp2.210]

  • Tejo-Otero A, Fenollosa F, Uceda R, Castellvi A, Lusting P, Valls-Esteve A, Ayats-Soler M, Munuera-del Cerro JL, Buj-Corral I and Krauel L.

    3D Printed Prototype of a Complex Neuroblastoma for Preoperative Surgical Planning

    Annals of 3D Printed Medicine . : 100014.

    [doi:10.1016/j.stlm.2021.100014]

  • Martin-Serrano J, Castellano JJ, Marrades RM, Canals J, Viñolas N, Díaz T, Molins L, Martinez D, Han B, Moisés J, He Y, Monzó M and Navarro A.

    Role of the epithelial-mesenchymal transition-related circular RNA, circ-10720, in non-small-cell lung cancer.

    Translational Lung Cancer Research . 10(4): 1804-1818. Nº de cites: 12

    [doi:10.21037/tlcr-20-920]

  • Bao R, Ng A, Sasaki M, Esai Selvan M, Katti A, Lee H, Huang L, Skol AD, Lavarino C, Salvador-Hernandez H, Klein RJ, Gümüs ZH, Mora J and Onel K.

    Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility

    CANCER PREVENTION RESEARCH . 14(4): 441-453. Nº de cites: 2

    [doi:10.1158/1940-6207.CAPR-20-0094]

  • Skowron P, Farooq H, Cavalli FMG, Morrissy AS, Ly M, Hendrikse LD, Wang EY, Djambazian H, Zhu H, Mungall KL, Trinh QM, Zheng T, Dai S, Stucklin ASG, Vladoiu MC, Fong V, Holgado BL, Nor C, Wu X, Abd-Rabbo D, Bérubé P, Wang YC, Luu B, Suarez RA, Rastan A, Gillmor AH, Lee JJY, Zhang XY, Daniels C, Dirks P, Malkin D, Bouffet E, Tabori U, Loukides J, Doz FP, Bourdeaut F, Delattre OO, Masliah-Planchon J, Ayrault O, Kim SK, Meyronet D, Grajkowska WA, Carlotti CG, de Torres C, Mora J, Eberhart CG, Van Meir EG, Kumabe T, French PJ, Kros JM, Jabado N, Lach B, Pollack IF, Hamilton RL, Rao AAN, Giannini C, Olson JM, Bognár L, Klekner A, Zitterbart K, Phillips JJ, Thompson RC, Cooper MK, Rubin JB, Liau LM, Garami M, Hauser P, Li KKW, Ng HK, Poon WS, Yancey Gillespie G, Chan JA, Jung S, McLendon RE, Thompson EM, Zagzag D, Vibhakar R, Ra YS, Garre ML, Schüller U, Shofuda T, Faria CC, López-Aguilar E, Zadeh G, Hui CC, Ramaswamy V, Bailey SD, Jones SJ, Mungall AJ, Moore RA, Calarco JA, Stein LD, Bader GD, Reimand J, Ragoussis J, Weiss WA, Marra MA, Suzuki H and Taylor MD.

    The transcriptional landscape of Shh medulloblastoma

    NATURE COMMUNICATIONS . 12(1): 1749-1749. Nº de cites: 45

    [doi:10.1038/s41467-021-21883-0]

  • Mora J, Castañeda-Heredia A, Colombo MC, Gorostegui M, Fernando Gómez Muñoz, Mañe S, Santa-María López V, Garraus-Oneca M, Macias N, Pérez-Jaume S, Muñoz-Aznar O, Muñoz JP, Barber-Martínez de la Torre I and Suñol M.

    Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma

    Cancers . 13(6): 164. Nº de cites: 7

    [doi:10.3390/cancers13061264]

  • Duhme C, Busch M, Heine E, de Torres C, Mora J and Royer-Pokora B.

    WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1

    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY . 43(2): 180-183. Nº de cites: 5

    [doi:10.1097/MPH.0000000000001697]

  • Vega-García N, Pérez-Jaume S, Esperanza-Cebollada E, Vicente-Garces C, Torrebadell-Burriel M, Jiménez-Velasco A, Ortega M, Llop M, Abad L, Vagace JM, Minguela A, Pratcorona M, Sánchez-Garcia J, García-Calderon CB, Gómez-Casares MT, Martín-Clavero E, Escudero A, Riñón M, Muñoz L, Velasco MR, García-Morín M, Català-Temprano A, Pascual A, Velasco P, Fernandez JM, Lassaletta A, Fuster JL, Badell I, Molinos-Quintana A, Molinés A, Guerra-Garcia P, Pérez-Martínez A, García-Abós M, Robles R, Pisa S, Adán R, Díaz de Heredia C, Dapena JL, Rives-Solà S, Ramirez M and Camós-Guijosa M.

    Measurable Residual Disease Assessed by Flow-Cytometry Is a Stable Prognostic Factor for Pediatric T-Cell Acute Lymphoblastic Leukemia in Consecutive SEHOP Protocols Whereas the Impact of Oncogenetics Depends on Treatment.

    Frontiers in pediatrics . 8: 614521-614521. Nº de cites: 5

    [doi:10.3389/fped.2020.614521]

  • Aschero MR, Francis JH, Ganiewich D, Gomez-Gonzalez S, Sampor C, Zugbi S, Ottaviani D, Lemelle L, Mena M, Winter U, Correa Llano G, Lamas G, Lubieniecki F, Szijan I, Mora J, Podhajcer O, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lavarino C and Chantada G.

    Recurrent Somatic Chromosomal Abnormalities in Relapsed Extraocular Retinoblastoma

    Cancers . 13(4): 673. Nº de cites: 14

    [doi:10.3390/cancers13040673]